These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28593701)

  • 21. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
    Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
    World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
    Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
    World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial.
    Han E; Lee YH; Lee BW; Kang ES; Cha BS
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
    Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
    Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
    Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial.
    Yancy WS; Olsen MK; Guyton JR; Bakst RP; Westman EC
    Ann Intern Med; 2004 May; 140(10):769-77. PubMed ID: 15148063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifestyle Modification through Dietary Intervention: Health Promotion of Patients with Non-Alcoholic Fatty Liver Disease.
    Arefhosseini SR; Ebrahimi-Mameghani M; Farsad Naeimi A; Khoshbaten M; Rashid J
    Health Promot Perspect; 2011; 1(2):147-54. PubMed ID: 24688911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.
    Schwimmer JB; Ugalde-Nicalo P; Welsh JA; Angeles JE; Cordero M; Harlow KE; Alazraki A; Durelle J; Knight-Scott J; Newton KP; Cleeton R; Knott C; Konomi J; Middleton MS; Travers C; Sirlin CB; Hernandez A; Sekkarie A; McCracken C; Vos MB
    JAMA; 2019 Jan; 321(3):256-265. PubMed ID: 30667502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
    Wong VW; Chan RS; Wong GL; Cheung BH; Chu WC; Yeung DK; Chim AM; Lai JW; Li LS; Sea MM; Chan FK; Sung JJ; Woo J; Chan HL
    J Hepatol; 2013 Sep; 59(3):536-42. PubMed ID: 23623998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects.
    Haufe S; Engeli S; Kast P; Böhnke J; Utz W; Haas V; Hermsdorf M; Mähler A; Wiesner S; Birkenfeld AL; Sell H; Otto C; Mehling H; Luft FC; Eckel J; Schulz-Menger J; Boschmann M; Jordan J
    Hepatology; 2011 May; 53(5):1504-14. PubMed ID: 21400557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; de la Fuente B; Bachiller R
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1041-7. PubMed ID: 24763885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
    Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
    J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.
    Guo CH; Chen WL; Liao CH; Huang K; Chen PY; Yang CP
    Int J Med Sci; 2018; 15(11):1194-1202. PubMed ID: 30123057
    [No Abstract]   [Full Text] [Related]  

  • 38. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
    Guo XF; Gao JL; Li JM; Li D
    Food Funct; 2017 Nov; 8(11):4053-4061. PubMed ID: 28972610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease.
    Yu H; Jia W; Guo Z
    J Clin Med; 2014 Sep; 3(3):1050-63. PubMed ID: 25411646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.